类似急性原核细胞白血病的AML:遗传视角和临床影响
Luca Guarnera1, Emiliano Fabiani2,3, Giulia Falconi2,4
1PhD in Immunology, Molecular Medicine and Applied Biotechnology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.
急性促细胞白血病 (APL) 是一种可治愈的AML亚型. 罕见的APL类AML病例缺乏t(15;17) 转位,存在诊断挑战和异质特征.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 急性骨髓细胞白血病 (APL) 是急性骨髓细胞白血病 (AML) 的一个独特的亚型,其特征是t(15;17) 转位.
- 针对性治疗,如全转网红酸 (ATRA) 和三氧化 (ATO) 显著改善了APL的治愈能力.
- 一小部分AML病例表现出类似APL的形态或免疫表型,但缺乏t(15;17) 转位,这给诊断和治疗带来了挑战.
研究的目的:
- 对罕见的APL类AML实体进行全面的文献审查.
- 为了研究潜在的白血病发生机制.
- 评估临床特征,并讨论未来的研究和治疗策略.
主要方法:
- 关于类似APL的AML的病例报告和研究的文献综述.
- 对遗传病变,临床表现和治疗反应的分析.
- 综合当前关于诊断,生物学和预后的知识.
主要成果:
- 自20世纪90年代初以来,已经确定了40多个不同的APL类AML实体.
- 这些实体在遗传改变,临床特征和治疗敏感性方面表现出显著的异质性.
- 诊断这些罕见的疾病尤其具有挑战性.
结论:
- 没有t(15;17) 的类似APL的AML代表了一组罕见髓质瘤的异质群.
- 进一步的研究对于了解它们的生物学和开发有针对性的治疗方法至关重要.
- 需要改进的诊断策略来管理这些具有挑战性的血液恶性瘤.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Differentiation of Common Myeloid Progenitor Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Lineage Commitment
